Doctors Protein RNA Vaccine 
pharmaphorum
DECEMBER 21, 2020
Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA vaccines against COVID-19. But the tragic events of 2020 have meant these companies have become household names as their trailblazing mRNA vaccines became the first to be approved by regulators against the COVID-19 scourge.
STAT News
MARCH 6, 2023
Still, when doctors told her last year that the cancer was growing despite two operations, radiation therapy, and a fifth regimen of chemotherapy, the retired business-meeting facilitator decided to do something unorthodox: spend $83,000 out of pocket on an unproven experimental cancer vaccine.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
FEBRUARY 1, 2023
RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.
Drug Discovery World
NOVEMBER 13, 2023
Ahead of protein and antibody engineering conference PEGS Europe 2024 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting. Ali Madani, PhD, Founder and CEO, Profluent Bio, on: ‘Protein engineering with large language models’.
pharmaphorum
AUGUST 23, 2022
With COVID-19 vaccines and therapeutics developed in rapid time, Ben Hargreaves investigates why this has not been the case with the creation of a treatment for Long COVID. Once the scale of the threat was understood, the pharmaceutical industry reacted with a rapidity and agility that allowed vaccines to be developed at a record rate.
Druggist
SEPTEMBER 2, 2021
Researchers continue to praise its efficacy in combating single strand RNA viruses including SARS-CoV-2. Researchers also praise its efficiency in combating anti-virus belonging to single-strand RNA viruses, including SARS-CoV-2. What does the research say about this? So, consult the doctors before self-medicating.
Druggist
SEPTEMBER 2, 2021
Researchers continue to praise its efficacy in combating single strand RNA viruses. Researchers also praise its efficiency in combating anti-virus belonging to single-strand RNA viruses, including SARS-CoV-2. They continued by mentioning its ability to eliminate all viral RNA (ribonucleic acid), including coronavirus, in 48 hours.
Expert insights. Personalized for you.
111 
Let's personalize your content